National trends in statin use by coronary heart disease risk category - Wikidata - thesis-toulmin - TriplyDB

National trends in statin use by coronary heart disease risk category

National trends in statin use by coronary heart disease risk category

http://www.wikidata.org/entity/Q24810059

about

Managing cardiovascular risk factors: the gap between evidence and practice.How do we improve patient compliance and adherence to long-term statin therapy?Time trends in the prescription of statins for the primary prevention of cardiovascular disease in the United Kingdom: a cohort study using The Health Improvement Network primary care data Knowledge and attitudes of primary care physicians in the management of patients at risk for cardiovascular events.Cholesterol treatment with statins: who is left out and who makes it to goal?Cardiovascular risk and statin use in the United States Appropriateness of cholesterol management in primary care by sex and level of cardiovascular risk.Quality of US primary care delivered by resident and staff physicians.Racial/ethnic differences in dyslipidemia patterns.Clinical utility of a novel coronary heart disease risk-assessment test to further classify intermediate-risk patients A prospective evaluation of C-reactive protein levels and colorectal adenoma development.Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study.Initiation rates of statin therapy for the primary prevention of cardiovascular disease: an assessment of differences between countries of the UK and between regions within England.Coenzyme Q10 and cognition in atorvastatin treated dogs.Coronary artery calcium in relation to initiation and continuation of cardiovascular preventive medications: The Multi-Ethnic Study of Atherosclerosis (MESA)Behavioral strategies for cardiovascular risk reduction in diverse and underserved racial/ethnic groups Drivers of the Sex Disparity in Statin Therapy in Patients with Coronary Artery Disease: A Cohort Study Cardiovascular care guideline implementation in community health centers in Oregon: a mixed-methods analysis of real-world barriers and challenges.Cardiovascular health disparities: a systematic review of health care interventions.Racial and ethnic disparities in cardiovascular medication use among older adults in the United States Statin use in primary inflammatory breast cancer: a cohort study.Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines.Increase in lipid-lowering treatment rates among TRICARE beneficiaries: a population-based study.Prevalence and Factors Associated With Statin Use Among a Nationally Representative Sample of US Adults: National Health and Nutrition Examination Survey, 2011-2012.Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cells.Micronized fenofibrate: a useful choice for the correction of dyslipidemia in metabolic syndrome and Type 2 diabetes.Targeted case finding in the prevention of cardiovascular disease: a stepped wedge cluster randomised controlled trial.Effects of an evidence-based computerized virtual clinician on low-density lipoprotein and non-high-density lipoprotein cholesterol in adults without cardiovascular disease: The Interactive Cholesterol Advisory Tool.Race, ethnicity, and shared decision making for hyperlipidemia and hypertension treatment: the DECISIONS survey.Association of statin use with peripheral neuropathy in the U.S. population 40 years of age or older.Trends in reported visual impairment in United States adults.Pattern of statin exposures reported to Texas poison centers, 1998-2004.Patient and other factors influencing the prescribing of cardiovascular prevention therapy in the general practice setting with and without nurse assessment.When is evidence sufficient for decision-making? A framework for understanding the pace of evidence adoption.Treatment gaps and potential cardiovascular risk reduction from expanded statin use in the US and England.Patterns of Statin Use in Older Medicare Beneficiaries With Traumatic Brain Injury.

P2860

Q24810063-E7DF0E4E-1810-42CB-8353-D49CD4573CC1 Q27691392-9C5343F4-DA07-4619-A6FC-0A075C2552B6 Q31108693-F06FD837-74F9-4522-A21D-62EAB3C6F9A1 Q33350064-44BE312D-7EBF-4D24-8F7C-92C1440DE16C Q33541739-BA33ED19-1CE0-4BF5-85E3-A25865DD58A0 Q33599663-08663ADE-492C-490F-A1D7-1CC661EB1375 Q34118658-67D2236F-C09A-42FE-9FF1-38243E72456C Q34164308-4647A825-EA03-442D-ADD0-13DF2A666875 Q34382652-F2C65C00-DD3B-49BA-B722-61D0082FA5F5 Q34507187-A6D7320B-C7A4-43E2-BADE-95A2FAB20815 Q34634479-F9798109-19BC-4B0E-8140-D341EA41726F Q34901608-03528780-2060-4448-90C1-29FC1CE2E4E3 Q35179448-3F1D598C-CA4F-4F2B-9A00-62299AD888E4 Q35215658-EAF4CB53-31B1-42C1-9801-3F9CAC018600 Q35482883-A457E142-87A8-4D04-9DAA-9895868E9B84 Q35800788-2708724E-14E1-42F7-8608-0BDF5BC32E48 Q36009362-0A36FF08-A42A-417F-BA7A-F3E544C9A913 Q36337117-2617819F-CC2E-4F89-818F-C26915DA0A27 Q36632231-A76BDE43-0EA5-4095-B358-3FA5829A8ADF Q36650525-6D977526-733E-41F7-A099-B818BD4EF457 Q37040602-D78ADFBD-C34D-442A-9471-4EFF9A66363A Q37224119-263F58F1-FE01-4D63-BC7D-EA8C2E76BBCF Q38449499-CADD7905-585C-4256-9A0E-AAF11F101252 Q39507722-2443837F-4DF4-41A9-A744-75CF694C8E67 Q39666388-8A8D57FF-3FD3-412B-891F-89CF89333133 Q40274682-100DF17E-6A42-4096-A76E-72F59331E3CD Q40397890-01DD5F3F-823B-40E6-9D60-42EE847A666F Q40617900-71A25029-3021-406F-A081-2BE6763AA4EE Q42873464-74D9D658-AEB8-4895-B302-DDE942E07BD3 Q43779477-A675358C-83EB-4B72-9F24-7C766FA5BC3D Q51128064-BF02170E-0D97-4CCC-9020-1FFF5C6C2D05 Q51742745-F96B4444-1338-4BBE-982B-2F2ECB0DCA01 Q53657751-A31217A1-D06B-436D-A65C-345134AAE74B Q53670933-899C3A5D-22BB-4006-A664-DEF3BB41D6F2 Q53678430-9D469611-3AFB-4D39-9EDC-0DC35D502F58 Q55250442-F7692EFB-B660-421C-88B2-839C4A8974F8

P2860

National trends in statin use by coronary heart disease risk category

http://www.wikidata.org/entity/Q24810059

description

2005 nî lūn-bûn

@nan

2005 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

National trends in statin use by coronary heart disease risk category

@ast

National trends in statin use by coronary heart disease risk category

@en

National trends in statin use by coronary heart disease risk category

@nl

type

label

National trends in statin use by coronary heart disease risk category

@ast

National trends in statin use by coronary heart disease risk category

@en

National trends in statin use by coronary heart disease risk category

@nl

prefLabel

National trends in statin use by coronary heart disease risk category

@ast

National trends in statin use by coronary heart disease risk category

@en

National trends in statin use by coronary heart disease risk category

@nl

P1433

Q24810059-9FD4E327-F631-4D40-9B6D-F1383ABA7437

P1476

Q24810059-AECB63CD-B377-4086-BD42-4FE05962EC4F

P2093

Q24810059-079B32BB-49A5-42AF-9D16-A14AEC38742A

Q24810059-31A4E4F9-0ADC-4651-B9E7-1BA481583DAA

Q24810059-B4E0C700-8008-4D96-A0A6-B5B44E8C32F7

Q24810059-C8FD9C87-D664-40FB-9C1C-8DF911E41C13

P2860

Q24810059-09D1103A-9402-4251-9A3A-FBCD2A8137E3

Q24810059-0D72ECFD-3116-4BB7-B8F5-694407E51ECB

Q24810059-26B6530D-94F2-4232-9442-3A8C17B9BD4B

Q24810059-2BB2490D-CE0A-41F2-8FEB-18821782CE5C

Q24810059-3A76E36B-F485-4B7A-B5B0-19AE6DC4A923

Q24810059-5412C856-5E0D-42AA-803D-20AFAE26C099

Q24810059-5BF9B515-42DF-493A-B1CA-75F8EE7C4817

Q24810059-69112522-315B-4947-8685-39B9815715BC

Q24810059-775C4CCD-7FF9-4FE3-A057-A89BA99EC3DB

Q24810059-80AE6561-A73F-4B20-9A66-42512A362144

P304

Q24810059-46216394-F23A-4C89-BF9B-03498479843A

P31

Q24810059-BAE7E466-2830-4F15-93A9-29EF9F8AF3BD

P3181

Q24810059-3786B17D-644E-48FD-8234-F0CC263477DE

P356

Q24810059-1849E849-20C3-4D2F-80F8-93D43575757B

P407

Q24810059-326EB4EB-1D06-42FA-918B-981FC37D76F4

P433

Q24810059-1760B909-BA9A-460F-A2FE-6290693317B7

P478

Q24810059-7913D561-B3CB-48FE-A8C2-2ECEBF54EE5F

P577

Q24810059-C0317CFB-2052-4E17-AA4D-B4595A27F02E

P5875

Q24810059-1655BD9E-E0AA-4207-8FE1-F5BD1CBBA561

P698

Q24810059-3A1CF56F-A1C7-4FE3-9911-72D851CBC449

P932

Q24810059-0A70DD85-6D4C-4005-A32B-A02944B4619E

P3181

P356

JOURNAL.PMED.0020123

P1433

P1476

National trends in statin use by coronary heart disease risk category

@en

P2093

John Z Ayanian

http://www.w3.org/2001/XMLSchema#string

Jun Ma

http://www.w3.org/2001/XMLSchema#string

Niraj L Sehgal

http://www.w3.org/2001/XMLSchema#string

Randall S Stafford

http://www.w3.org/2001/XMLSchema#string

P2860

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Impact of evidence-based "clinical judgment" on the number of American adults requiring lipid-lowering therapy based on updated NHANES III data. National Health and Nutrition Examination Survey.

Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease.

Cholesterol risk management: a systematic examination of the gap from evidence to practice.

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

Low prevalence of lipid lowering drug use in older men with established coronary heart disease

Use of cholesterol-lowering therapy and related beliefs among middle-aged adults after myocardial infarction

Use of statins in the secondary prevention of coronary heart disease: is treatment equitable?

P304

e123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1229714

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PMED.0020123

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7826267

http://www.w3.org/2001/XMLSchema#string

P698

15916463

http://www.w3.org/2001/XMLSchema#string

P932

1140942

http://www.w3.org/2001/XMLSchema#string